Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -17.30M
March 31, 2026 -3.758M
December 31, 2025 -32.41M
September 30, 2025 -1.935M
June 30, 2025 -12.58M
March 31, 2025 -0.544M
December 31, 2024 -11.06M
September 30, 2024 -1.72M
June 30, 2024 -11.04M
March 31, 2024 -6.466M
December 31, 2023 -6.845M
September 30, 2023 -236.00M
June 30, 2023 -9.312M
March 31, 2023 -2.301M
December 31, 2022 -438.17M
September 30, 2022 -1.393M
June 30, 2022 -8.918M
March 31, 2022 -4.156M
December 31, 2021 -8.515M
September 30, 2021 -554.76M
June 30, 2021 -8.344M
March 31, 2021 -4.57M
December 31, 2020 -11.79M
September 30, 2020 -275.62M
June 30, 2020 -10.04M
Date Value
March 31, 2020 -3.826M
December 31, 2019 -220.62M
September 30, 2019 -4.433M
June 30, 2019 -113.15M
March 31, 2019 -2.578M
December 31, 2018 -3.03M
September 30, 2018 -104.64M
June 30, 2018 -5.487M
March 31, 2018 -0.565M
December 31, 2017 -2.322M
September 30, 2017 -0.895M
June 30, 2017 -2.029M
March 31, 2017 -0.413M
December 31, 2016 -2.492M
September 30, 2016 -0.454M
June 30, 2016 -1.932M
March 31, 2016 -1.306M
December 31, 2015 -0.631M
September 30, 2015 -182.68M
June 30, 2015 2.055M
March 31, 2015 -0.003M
September 30, 2014 0.267M
June 30, 2014 1.054M
March 31, 2014 0.285M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. -28.29M
CareDx, Inc. 9.481M
Myriad Genetics, Inc. -2.80M
BioRestorative Therapies, Inc. -4.441M
Exagen, Inc. 0.00